Show simple item record

dc.contributor.authorMoore, B.
dc.contributor.authorSalman, S.
dc.contributor.authorBenjamin, J.
dc.contributor.authorPage-Sharp, Madhu
dc.contributor.authorYadi, G.
dc.contributor.authorBatty, Kevin
dc.contributor.authorSiba, P.
dc.contributor.authorMueller, I.
dc.contributor.authorDavis, T.
dc.identifier.citationMoore, B. and Salman, S. and Benjamin, J. and Page-Sharp, M. and Yadi, G. and Batty, K. and Siba, P. et al. 2015. Pharmacokinetics of piperaquine transfer into the breast milk of Melanesian mothers. Antimicrobial Agents and Chemotherapy. 59 (7): pp. 4272-4278.

Transfer of piperaquine (PQ) into breast milk was examined in 27 Papua New Guinean women given a 3-day course of dihydro-artemisinin-PQ or sulfadoxine-pyrimethamine-PQ during the second/third trimester. Breast milk was sampled on days 1, 2, 3 to 5, 7 to 11, and 14 to 17 postdelivery, a median of 70 days postdose (range, 6 to 145 days). A blood sample was taken at delivery, and additional serial samples were available from 9 women who delivered within 42 days of dosing. Milk and plasma PQ were assayed by high-performance liquid chromatography. A population-based approach was used to model the log<inf>e</inf>(plasma) and milk concentration-time data. A sigmoid E<inf>max</inf> model best described PQ breast milk transfer. The population average milk: plasma PQ ratio was 0.58, with a peak of 2.5 at delivery. The model-derived maximum milk intake (148 ml/kg of body weight/day) was similar to the accepted value of 150 ml/kg/day. The median estimated absolute and relative cumulative infant PQ doses were 22 µg and 0.07%, respectively, corresponding to absolute and relative daily doses of 0.41 µg/kg and 0.004%. Model-based simulations for PQ treatment regimens given at birth, 1 week postdelivery, and 6 weeks postdelivery showed that the highest median estimated relative total infant dose (0.36%; median absolute total dose of 101 µg/kg) was seen after maternal PQ treatment 6 weeks postpartum. The maximum simulated relative total and daily doses from any scenario were 4.3% and 2.5%, respectively, which were lower than the recommended 10% upper limit. Piperaquine is transferred into breast milk after maternal treatment doses, but PQ exposure for suckling infants appears safe.

dc.publisherAmerican Society for Microbiology
dc.titlePharmacokinetics of piperaquine transfer into the breast milk of Melanesian mothers
dc.typeJournal Article
dcterms.source.titleAntimicrobial Agents and Chemotherapy
curtin.departmentSchool of Pharmacy
curtin.accessStatusOpen access via publisher

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record